Actively Recruiting
Pain During Cesarean Delivery: a Patient-Centered Assessment Tool Developed With Mixed Methods
Led by University Hospital, Basel, Switzerland · Updated on 2026-04-29
15
Participants Needed
1
Research Sites
4 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are developing a standardized tool to assess pain experienced during cesarean delivery under neuroaxial anesthesia. This study focuses on understanding patient experiences and expert clinical opinions to create a meaningful pain assessment tool. The aim is to incorporate patient priorities and scientific evidence through a structured consensus process involving experts from various disciplines. The study involves a mixed-methods approach, including expert input through a Delphi process to identify key pain assessment items and patient interviews to capture individual pain experiences and informational needs. These activities will help shape a patient-centered tool for evaluating pain during cesarean sections. Participants will be women who had elective cesarean deliveries under neuraxial anesthesia within the last 48 to 72 hours. Researchers will conduct interviews to learn about patient experiences and gather expert opinions to finalize the assessment tool. The primary outcome is the development of a consensus-based pain assessment tool measured 48 to 72 hours after surgery. Secondary outcomes include identifying patient information priorities during qualitative interviews. The study is observational and aims to complete by August 2026.
CONDITIONS
Brief Title
Development of a Patient-Centered Assessment Tool for Pain During Cesarean Delivery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Signed informed consent
- Age > 18 years
- Proficient in German or Swiss German
- Elective cesarean delivery under neuraxial anesthesia in last 48-72 hours
- Delivery of a healthy infant of at least 35+1 weeks of gestation
You will not qualify if you...
- Known fetal abnormalities or neonatal death
- Admission of the neonate to the ICU
- Severe postpartum hemorrhage of >1000ml blood loss
- Preeclampsia
- Current psychiatric disease, e.g. schizophrenia, personality disorders
- Substance abuse
- Chronic pain disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 48 to 72 hours postoperatively
Participants undergo assessments related to pain during cesarean delivery and participate in qualitative interviews about their informational priorities.
1 visit (in-person)
Duration - Up to 72 hours after cesarean delivery
Participants are observed following cesarean delivery to monitor pain and related outcomes.
1 visit (in-person)
Trial Site Locations
Total: 1 location
1
University Hospital Basel
Basel, Canton of Basel-City, Switzerland
Actively Recruiting
Research Team
L
Lena Gschwandtner
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here